Articles by Sarah Mitchell
ASX: BXN Bioxyne's $50M German Cannabis Deal — Is the 295% Rally Justified?
Bioxyne (ASX: BXN) has locked in a $50 million, two-year exclusive supply agreement with German pharmaceutical distribut...
Why Andrew Forrest Just Bought Into EQ Resources (ASX: EQR) — And What It Means for Australia's Tungsten Story
EQ Resources (ASX: EQR) shares jumped 34% on 20 July 2026 after it emerged that Andrew Forrest's private investment vehi...
Are Commonwealth Bank (ASX: CBA) Shares an Absolute 'Sell' at Current Record Multiples?
Australian investors are grappling with a tricky question that doesn't have an easy answer: How do you sell a stock that...
BHP vs. Rio Tinto (ASX 200): Which Mining Heavyweight Should You Buy as Commodity Prices Rebound?
Copper is once again near its all-time highs. Iron ore prices continue to trade above US$109 per tonne, when expectation...
Australia's Q1 GDP Data Drops Wednesday — Here's What the Numbers Could Mean for the ASX
Wednesday June 3 will be an extremely significant day on the Australian economic schedule this week," according to exper...
Cochlear in 2026 — Ugly Short Term, But Is the Story Broken?
Down 61% for the year. Guidance slashed nearly in half. It has been a really rough stretch for COH shareholders. But ste...